Eli Lilly said on Monday it will buy Loxo Oncology Inc for $8 billion, an expensive bet on a pipeline of cancer drugs that target rare genetic mutations and the biggest acquisition in the drugmaker's 143-year history. The price represents a 68 percent premium to Loxo's Friday share price close, which some Wall Street analysts said was high for a company with only one drug on the market that it shares with a partner.
from Reuters: Top News https://reut.rs/2VAc5hg Eli Lilly said on Monday it will buy Loxo Oncology Inc for $8 billion, an expensive bet on a pipeline of cancer drugs that target rare genetic mutations and the biggest acquisition in the drugmaker's 143-year history. The price represents a 68 percent premium to Loxo's Friday share price close, which some Wall Street analysts said was high for a company with only one drug on the market that it shares with a partner.
Venezuela's Guaido readies to open up oil industry after years of nationalizationVenezuelan congress head Juan Guaido is preparing a groundbreaking reversal of late President Hugo Chavez's energy industry nationalization, allowing … Read More
0 comments:
Post a Comment